Table 1

Characteristics of 20 patients

Case no.Age (y)/sexHBs AgHCV AbChild gradeCirrhosisAFP*Edmondson classificationMain tumor size (cm)Cycles of chemotherapyResponse
174/M+APresentLow33.03CR
267/F+APresentHigh39.23CR
349/F+AAbsentHigh46.83PD
447/M+APresentHigh312.03PD
551/FBAbsentHigh315.03PR
656/MBPresentLow20.83PD
769/M+AAbsentHigh38.03CR
866/M++APresentHigh34.03CR
965/M+BPresentHigh31.32PD
1053/M+APresentHigh317.03PD
1152/M+BAbsentHigh318.03CR
1266/MBPresentHigh33.51PD
1339/M+BPresentHigh34.51PD
1456/M+APresentHigh35.53SD
1567/M+APresentHigh33.22PD
1647/M+AAbsentHigh313.03PD
1770/M+AAbsentLow39.43CR
1870/M+AAbsentHigh39.83CR
1971/M+AAbsentHigh39.03PD
2029/M+AAbsentHigh318.02PD
  • Abbreviations: HBs Ag, hepatitis B surface antigen; HCV Ab, hepatitis C virus antibody; SD, stable disease.

  • * Divided into either low (≤50 ng/mL) or high (>50 ng/mL).

  • Assessment based on ECOG criteria.